Alprazolam
- Product NDC
- 66267-564
- Requested package NDC
- 66267-564-90
- 11-digit product format
- 662670564
- Labeler code
- 66267
- Product ID
- 66267-564_b8a7b0c8-25da-5d2c-e053-2995a90a0006
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprazolam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA074909
- Marketing category
- ANDA
- Marketing start
- 1998-03-25
- Marketing end
- 0000-00-00
- Substance
- ALPRAZOLAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 66267-564 | 66267-564-90 | I | Inactivated by FDA | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074909-001 | ALPRAZOLAM | ALPRAZOLAM | 2MG | TABLET / ORAL | AB | 1998-03-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A074909-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074909-001 | ALPRAZOLAM | 2MG | TABLET / ORAL | AB | 1998-03-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074909-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | A-S Medication Solutions | 3c0cb60f-1c3a-48a6-ad16-f14351548412 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 7538d0d0-346e-4c3e-8f7a-c1cac8ec8ed3 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Sandoz Inc | d9b0e228-17cf-40d7-b62e-5050311c571c | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Bryant Ranch Prepack | b0000772-2514-45a2-a75d-1bbb13c29989 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Proficient Rx LP | 717ce509-f92e-4ec1-a3c6-aeae54d56f4d | 2020-08-01 | Warnings, Adverse reactions | 074909 ANDA074909 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2ffbe5ef-58ff-88b9-e291-045e0f861f4f | Product name | 4 | 20180827 |
| 1f9e6d58-49d3-d9c1-e570-4bb0466a2c0b | Product name | 1 | 20140508 |
| a1a11520-f3e2-68fa-8bd9-e80b271ef797 | Product name | 1 | 20140508 |
| d153678e-a3c8-bad8-cfe0-385656dde0e7 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66267-564-30 | 2023-01-30 | C162847 | 48780-1 | f386c649-9f3a-0266-e053-dadaa90a7c1a | Alprazolam Tablets, USP |
| 66267-564-60 | 2023-01-30 | C162847 | 48780-1 | f386c649-9f3a-0266-e053-dadaa90a7c1a | Alprazolam Tablets, USP |
| 66267-564-90 | 2023-01-30 | C162847 | 48780-1 | f386c649-9f3a-0266-e053-dadaa90a7c1a | Alprazolam Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66267-564-30 | Alprazolam | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 66267-564-60 | Alprazolam | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 66267-564-90 | Alprazolam | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197322 | ALPRAZolam 2 MG Oral Tablet | PSN | 60bb0c7a-5ab1-2ba8-e053-2a91aa0a1ec9 | 2 |
| 197322 | alprazolam 2 MG Oral Tablet | SCD | 60bb0c7a-5ab1-2ba8-e053-2a91aa0a1ec9 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66267-564-90 | 66267056490 | 90 TABLET in 1 BOTTLE (66267-564-90) | 90 tablet | 2017-12-19 | 0000-00-00 | No | No | Current |